Comparative Effectiveness of Atezolizumab Plus Bevacizumab Versus Tremelimumab Plus Durvalumab in Patients with Hepatocellular Carcinoma (HCC) in a Real-World Setting

Targeted Oncology · Published 2025-06-23 · DOI 10.1007/s11523-025-01161-5

Authors being retrieved — see the publisher record. https://doi.org/10.1007/s11523-025-01161-5

Abstract

PubPorta does not have an abstract for this article yet.

Read the article at the publisher →

Publication details

Year
2025

Related articles